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Methods, systems, and devices to reduce power demands
substantially for current deep brain stimulation DBS using
smart technology type applications. The invention uses miniaturized components that allow integration with the
implanted probe(s) themselves, and includes a skull-sited
housing having all the controls and battery power supply
needed. This avoids implanting obtrusive card-deck size batteries in the chest area and the use of vulnerable wire leads
under the skin from the chest area to connect with the
implanted electrode(s) on the skull, improving comfort. The
Generating of non-continuous pulses on demand of conditions such as the occurrence of a tremor occurs, without
having to continuously run pulses at all times, substantially
increasing life spans over current techniques. Shaped electrodes and their methods further reduce power demands and
efficacy by directing electric fields to focus towards specific
areas and regions of the brain rather than inefficient 360degree emission.

18 Claims, 12 Drawing Sheets
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SPATIAL-TEMPORAL DEEP BRAIN
STIMULATION METHODS AND SYSTEMS

2

toms. The advantage of surgical ablation is that it reduces the
reliance on drug therapy with its attendant side effects. The
disadvantage is that the procedure is irreversible. This may
render such patients as unacceptable candidates for newly
This invention claims the benefit of priority to U.S. Providiscovered techniques/therapies, such as stem cell implantasional Patent Application Ser. Nos. 60/512,660 filed Oct. 20,
2003, and 60/586,468 filed Jul. 8, 2004.
tion or viral transport of genome-altered DNA (deoxyribonucleic acid), both of which show promise in helping to
FIELD OF INVENTION
augment or even to regenerate the natural production of
dopamine as well as a number of other substances involved in
This invention relates to deep brain stimulation (DBS), in 10 neurological disorders.
particular to methods, systems, and devices for enhancing
Certain neurological disorders that produce debilitating
both efficacy and efficiency of "in-vitro" electrical stimulamotor symptoms are now being treated with Deep Brain
tion known to inhibit symptoms of neurological diseases,
Stimulation (DBS) through-sknll implanted electrodes see
disorders, and the like, and utilizes: (a) methods that tailor the
FIG. 1 below. DBS essentially reversibly alters the local
direction and shape of electrical fields towards the area ofbest 15
neurological structure(s) around the tip of an electrode
effect; (b) systems that interactively trigger stimulation to
implanted on the brain with electrical pulses that reduce or
terminate the onset of tremors, and such; and (c) devices that
stop disabling symptoms, such as, but not limited to, severe
use the aforementioned efficiencies to reduce power and
tremor and rigidity found in Parkinson's disease.
allow for self-contained miniaturization at the implant site,
DBS functionally has the advantage of emulating ablation
20
thereby improving patient comfort.
by changing the firing characteristics of nearby neurons, but it
does so only while the pulsed stimulation persists. Since the
BACKGROUND AND PRIOR ART
structures remain intact and undamaged, when DBS is turned
"off' these structures reactivate and symptoms return, unless
A first line of defense considered for most neurological
disorders is treatment with psychoactive medicines, prior to 25 otherwise treated. Thus, DBS overcomes the chief disadvantage of ablation in that it allows implanted simulators to be
any surgical intervention. Psychoactive medicines or drugs
withdrawn later for new techniques, with minimal residual
are those capable of acting on the nervous system and affecting mental states and behavior. Many physiological mechaeffects. In 1998, the Federal Drug Administration (FDA)
nisms are aided by such drugs, but these medicines have
approved DBS as an alternative for, or as an adjunct to powunwanted side effects, drug interactions, and long-term 30 erful psychoactive drugs (neuro-medicines) burdened with
strong and often unacceptable side effects.
physiological tolerances that render the drug less effective
The only FDA approved DBS apparatus is currently being
overtime.
In the case of Parkinson's disease that serves as the exemsold by Medtronic, Inc., 710 Medtronic Parkway, Minneapoplar disorder herein, the underlying etiology is that neurons,
lis, Minn. 55432-560, see FIGS. 2 and3 below, although other
located in the substantia nigra of the mid-brain, for some 35 companies have substantial interests in implantable neurounknown reason begin to produce less dopamine. As these
stimulation devices for a variety of neurological disorders,
neurons progressively and relentlessly deteriorate over years,
such as Advanced Bionics, Corp., 127 40 San Fernando Road,
Sylmar, Calif. 91342; see "http://www.advanced bionicless dopamine dramatically affects the motor control of the
basal ganglia and thus outward behavior and everyday living.
s.com." However, there are problems with the approved appaAn estimated 1.5 million Parkinson's patients have a visible 40 ratus.
cluster of diagnostically significant and debilitating ParkinAt the very least, the presently approved apparatus is cumson's symptoms, typically tremors, stiffness, slowness, and
bersome and uncomfortable for many in its present form. As
balance. Patients describe the internal feeling as frozen still in
an outgrowth of legacy components from heart "pacemakthe "set" stage of the "ready, set, go" sequence that started of
ers," it consists of one or two remote stimulator/battery packs
a race.
45 embedded under muscle tissue in the upper chest area, and
The "gold" standard treatment for Parkinson's is frequent
requires subcutaneous leads up along the neck to the skull
daily administration of an indirect dopamine replacement,
entry point. All these components are subject to corrosion and
L-Dopa, a psychoactive drug that crosses the blood-brain
breakage, as well as to resistance or attacks by the body itself
attempting by encapsulate it or dissolve it, leading to infecbarrier, and then alters form to produce dopamine as a supplement to the brain's own production. This therapy, while ini- 50 tion.
tially quite beneficial, typically can lose much ofits effectiveMedtronic currently uses a product called a Soletra™ Neuness over about five years, wherein patients have to take
rostimulator (see FIG. 4 below) to generate a continuous
progressively larger and more frequent doses until eventually
series of electrical pulses, typically at about 2-4 volts, to
electrode(s) implanted in specific brain areas. Neurons, northe result becomes inadequate. Without alternative drug
therapies, patients are left to suffer both the ravages of pri- 55 mally operating in the tens of milli-volts range, are massively
mary symptoms and the manifestations resulting from the
over-stimulated by such voltage and temporally altered,
prolonged use of the drug itself, principally the repetitive
thereby inhibiting the expression of certain motor dysfuncspasmodic motions of dyskinesia. More than one million
tions. Pulse voltage is usually adjusted somewhat depending
on the proximity of the electrode(s) to the targeted area, e.g.,
people endure these symptoms, including such notables as the
Pope, Muhammad Ali, and Billy Graham, while thousands of 60 more voltage is needed for target variations. Typical pulse
others including Michael J. Fox have turned to surgical
rates range around 130-185 pulses/second.
approaches.
This combination of large amounts of voltage, amperage,
Past surgical techniques treated symptoms of these disand duty cycle creates a power drain that normally requires a
eases by selectively and permanently destroying or ablating
non-renewable battery replacement in about 3-5 years, at a
structural areas in the brain. The net effect is to "shut the 65 price of about $10,000. Many patients turn "off' the stimudoor", in a neurological fashion, before dysfunctional brain
lation when going to sleep while tremor is quelled, in order to
signals are sent to the muscles, thereby relieving many sympconserve power. Current DBS stimulator(s) are designed to
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be turned "off' or "on" using a magnetic-switch placed
briefly near the associated electronics.
Thus, without considering the remote apparatus itself, or
the power requirements of the present design, a goal in this
field should be to reduce stimulation-related side effects and
complications caused by stimulating in the vicinity of the
target. Two key objectives to meeting that goal are for the
surgical implant to hit the center of a targeted cellular region,
often not more than 2 mm across in any direction, and for the
current field to stimulate the appropriate cells for symptom
reduction or cessation, without triggering side effects in adjacent structures.
While the surgical techniques themselves are well documented, the surgery is still a unique combination of art and
science [see Lozano, Andres M. (Ed): Movement Disorder
Surgery: Progress in Neurological Surgery, vol. 15, pp. 202208, Basel, Switzerland: Karger AG, 2000, ISBN 3-80556990-4.].
A key to a successful outcome is the precise positioning
and placement of the electrode(s ), aided pre-operatively by
vast improvements in brain imaging techniques, but nevertheless requiring considerable surgical skill and judgment.
Beside normal variations in brain structures themselves adding to the difficulty of targeting, during surgery the brain
moves with each heartbeat, while its size and position vary
somewhat as a result of the surgical probe itself altering
internal pressure. During the procedure, the use of fluoroscope imaging assists y-z axis positioning, and awakening of
the patient while in the operating room for testing of clinical
signs can reveal and help avoid untoward side effects. However, but the final outcome can only be assessed post-operatively. Results can vary by patient and over time. Some postsurgical adjustment is normally done with electrical
parameters and z-axis prograniming of one or more of the
electrode contacts available on the current DBS electrode, as
is described below, but not to the extent that many physicians
would like and not with respect to the x-y axis.
Current DBS electrodes have four (4) circumferential contacts that radiate current in a 360 degree configuration. This
means that with any degree off-target, or unnecessary stimulation even on target adjacent cells are exposed to current and
potential side effects. While some of these side effects may be
adjustable when electrical parameters are altered, or even
reversible when the stimulation is shut down, but the cost is
decreased efficacy of stimulation on the symptoms. For
example, in sub-thalamic nucleus DBS, stimulation-induced
side effects may include increased dyskinesias, blepharospasm or so called "eyelid-opening apraxia," confusion/
memory disturbances, personality changes, mood changes,
apathy, cognitive changes, dysphonia/dysarthria, and such.
Medtronic Inc. has proposed a "Directional Brain Stimulation and Recording Leads, title, in U.S. Published Patent
Application 2002/0183817 to Van Venrooij et al., which is
incorporated by reference. The proposed technique uses a
"controller" as shown and referenced to FIG. 32 for recording
"brain activity signals" to activate electrodes. However, this
technique requires continuously generating pulsed type signals once the electrodes are activated whether or not a brain
type tremor has ended, which would result in needless,
unwanted and potentially excessive electrical current being
continuously generated inside the brain. The more unnecessary pulse type signals, the more undesirable side effects to
the patient, for example, in thalamic DBS, stimulation-induced side effects may include paresthesias, muscular
cramps, dystonia, dizziness, dysarthria, gait and balance disturbances, limb ataxia, impaired proprioception, and
decreased fine motor movements.

Additionally, this technique would require excessive
power to operate, which is not only expensive since battery
power supplies would need to be regularly replaced but also
require large card-deck size batteries that must be mounted
inside of the patient's upper chest area. This proposed
Medtronic technique would also be prone to circuit problems
since the electrodes would be simultaneously operating as
both transmitters and sensors, causing excessive and unnecessary power drain, shortening the lifespan of any batteries
being used as well as increasing the costs for replacing the
batteries.
According to the Movement Disorder Society ©2002,
"Deep brain stimulation for the alleviation of movement disorders and pain is now an established therapy. However, very
little has been published on the topic ofhardware failure in the
treatment of such conditions irrespective of clinical outcome.
Such device-related problems lead to significant patient morbidity and increased cost of therapy in the form of prolonged
antibiotics, in-patient hospitalization, repeat surgery, and
device replacement [Joint, C., Nandi, D., Parkin, S., Gregory,
R., and Aziz, T. Hardware-Related Problems ofDeep Brain
Stimulation. Movement Disorders, Vol. 17, Suppl. 3, 2002,
pp. S175-S180.]
Thus, the need exists for solutions to the problems encountered in the prior art.
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A first objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that avoid implanting large card-deck size batteries remotely
in the chest area and the use of vulnerable wire leads under the
skin from the chest area to connect with the implanted electrode on the skull.
A second objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that allow for substantially all electronics including but not
limited to an on-site battery pack to be located at or near the
implanted electrodes on the skull.
A third objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems, and devices
that can use substantially less power than current DBS techniques and apparatus.
A fourth objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices,
that do not generate a continuous series ofun-synchronized
pulses that are continuously generated whether they are
needed or not.
A fifth objective of this invention is to provide for deep
brain stimulation (DBS) methods, systems and devices, to
generate pulses on demand. Specifically, inhibiting pulse(s)
can be interactively triggered by the onset of each unwanted
electro-physiologically signaled event, such as at the beginning of a tremor.
A sixth objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that are more compact, easier to use and last longer than
current DBS techniques, thereby improving patient comfort.
A seventh objective of the present invention is to provide
for shaped electrodes and methods by using the electrode
contacts in deep brain stimulation (DBS) methods, systems
and devices, that orient configured electrical fields to specific
points, preferentially directing current a targeted cellular
region and facilitating the clinical effect. The best direction of
the shaped current can be determined intra-operatively
through recordings and clinical testing along the "X-Y"
plane.
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An eighth objective of the present invention is to use
shaped electrodes in deep brain stimulation (DBS) methods,
systems and devices, in order to decrease off-target current
stimulation, thereby minimizing or eliminating exposure to
adjacent cellular regions that produce side effects.
A ninth objective of the present invention is to use the
decreased electrical "aperture" of shaped electrodes in deep
brain stimulation (DBS) methods, systems and devices, in
order to maintain current density on the target region, but with
less overall current flow and less battery drain over time.
Methods, systems and devices are provided for deep brain
stimulation (DBS), that can include providing a pulse stimulator with battery supply and controls within one unit, imbedding the single unit on a head ofa user, and generating a single
treatment pulse from the stimulator to the brain of the user, the
single pulse being generated on demand of a sensed initiation
of an impulse burst from a condition. Another single pulse can
be generated upon occurrence of a follow-up sensed impulse
burst. The impulse bursts can come from a detected brain
activity condition such as those associated with tremors, and
the like.
The methods, systems and devices can also include providing the battery power supply solely in a compact skullmounted cylindrical disc cap without implanting of batteries
in a chest area of the user and avoiding any use of wires under
skin from the chest area to connect to the stimulator, mounted
as a skull cap with the top cap disc cover and the bottom
cylindrical disc housing underneath and covered by the scalp,
with a single opening in the skull for the lead line, further
improving patient comfort.
Controls can also include filtering sensed signals from
electrode sensors to a noise amplitude filter, followed by
counting impulses in the filtered signals with an impulse
counter, and then triggering the single treatment pulse when a
selected threshold of the counted impulses has been reached.
Furthermore, controls can allow for shutting off the noise
amplitude filter, and the impulse counter when the triggering
of the single treatment pulse has been initiated.
Various types of directional components can be provided
for directing the treatment signals to effected areas of the
brain of the user.
Further objects and advantages of this invention will be
apparent from the following detailed description of the presently preferred embodiments, which are illustrated schematically in the accompanying drawings.

FIG. Sa shows a recording trace graph of neuronal impulse
bursts in mill volts verses time that can occur with an
untreated patient.
FIG. Sb shows a trace graph of associated tremor displacement for FIG. Sa in millimeters verses time that can occur
with the untreated patient.
FIG. 9 shows an exemplary flow chart of a triggering algorithm steps that can be used with the invention.
FIGS. 10, lOa and lOb shows a layout of the electronic
components that can be used in the apparatus of FIGS. Sa, Sb,
6 along with the triggering algorithm of FIG. 9.
FIG. lla shows a trace graph of the neuronal impulse
bursts in milli-volts verses time of a patient being treated with
a Medtronic type (prior art) technique.
FIG. llb shows a trace graph of the associated tremor
displacement for FIG. llb verses time of the patient being
treated with the Medtronic type (prior art) technique.
FIG. llc shows the continuing pulse train that occurs with
the Medtronic type (prior art) technique which causes the
trace graphs of FIGS. lla-llb.
FIG. 12a shows a trace graph of the neuronal impulse
bursts in milli-volts verses time of a patient being treated from
being treated by the subject invention.
FIG. 12b shows a trace graph of the associated tremor
displacement for FIG. 12a verses time of the patient being
treated by the subject invention.
FIG.12c shows the single pulses that occur with the subject
invention technique which results in the trace graphs of FIGS.
l2a-l2b.
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FIG. 1 shows a deep brain stimulation (DBS) apparatus of
the prior art.
FIG. 2 is a front view of the current prior art DBS of FIG.
1.
FIG. 3 shows DBS head-mounting details of the prior art of
FIGS. 1-2.
FIG. 4 shows another prior art product device.
FIG. Sa shows an open view of a miniaturized integrated
battery/stimulator apparatus of the subject invention.
FIG. Sb shows a closed view of the apparatus of FIG. Sa.
FIG. 6 shows the novel invention apparatus of FIGS. Sa-Sb
utilized in a head mounted application.
FIG. 7a shows enlarged side views of four shaped electrodes with projected fields used in the apparatus of FIGS. Sa,
Sb and 6.
FIG. 7b illustrates the axial views of the four shaped electrodes of FIG. 7a with respective projected fields.
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Before explaining the disclosed embodiments of the
present invention in detail it is to be understood that the
invention is not limited in its applications to the details of the
particular arrangements shown since the invention is capable
of other embodiments. Also, the terminology used herein is
for the purpose of description and not of limitation.
This invention provides methods, systems and devices to
reduce power demands substantially for DBS (deep brain
stimulation), allowing for miniaturized type components to
be integrated with the implanted probe(s) themselves, see
FIGS. Sa, Sb, 6and10. The invention avoids implanting large
and cumbersome card-deck size batteries in the chest area and
the use of vulnerable wire leads under the skin from the chest
area to connect with the implanted electrode(s) on the skull.
Notably, the remote stimulator/battery with its associated
wiring are the chief source of complaints in the use of this
technique. Other advantages ofthis invention are also apparent.
The invention substantially differs from that used in current techniques. Rather than generating a continuous series of
un-synchronized pulses that act whether needed or not, pulses
can be generated on demand. Specifically, inhibiting pulse(s)
can be interactively triggered by the onset of an unwanted
electro-physiologically signaled event, such as the beginning
of a tremor. The same electrode( s) that now serves as a oneway input also can serve as a bi-directional conduit to sense
the electrical beginnings of the event itself as well as delivering the pulse(s). Thus, with appropriately tailored, triggering algorithms, a preferred example of which is described
below in reference to FIG. 9, an inhibiting pulse can be timed
for delivery so as to suppress the event's full expression.
Using this approach, power drain reductions of conservatively 85% or more are achievable, with the percentage
depending on the neurological events of interest. For
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example, most tremors are less than approximately 10 tremor
cycles per second, and can be far less when the tremor is
interrupted by another intentional activity such as purposeful
movement, as in the case of Parkinson's disease. Thus, the
constant power drain can be reduced from approximately 150
stimulating pulses/second using the current techniques
described in the prior art to now to as little as one stimulating
pulse counteracting each tremor onset using interactive triggering.
Even greater power reductions are possible for "lower frequency" tremor, such as Essential tremor at approximately 5
to approximately 7 tremor cycles/ second, or "low-frequency"
Parkinson tremor at approximately 3 to approximately 5
tremor cycles/second.
With dramatically reduced power demands for DBS, this
invention then allows for miniaturized components to be integrated with the skull cap attachment to the implanted probe(s)
themselves, as shown in FIGS. Sa, Sb, 6and10.
FIG. Sa shows an open view of a miniaturized integrated
battery/stimulator apparatus 1 of the subject invention. FIG.
Sb shows a closed view of the apparatus 1 of FIG. Sa in a
cylindrical disc housing where the top cap covers the bottom
cylindrical disc of the disc housing. FIG. 6 shows the novel
invention apparatus 1 of FIGS. Sa-Sb utilized in a head
mounted application with the top cap disc cover and the
bottom cylindrical disc housing mounted as a skull cap underneath and covered by the scalp with the imbedded probe
extending downward from beneath a central portion of the
cylindrical housing through the skull and into the brain. As
shown in FIG. 6, the novel size of the cylindrical disc housing
and the cap mount application is compact and easier to use
than the prior art, and is not uncomfortable and cumbersome
to the user as in the prior art. The compact cylindrical disc
housing with miniaturized components does not cause a
noticeable protrusion above the scalp line and existing hair of
the user.
Referring to FIGS. Sa-Sb and 6, the hole cap 20 can include
a top cover 20T, and bottom cylindrical disc housing 20B to
house components 100 (which are described and shown in
greater detail in reference to FIG. 10). Underneath the cap 20
can be a lead line 30, and approximately four (4) directional
electrodes 40, SO, 60 and 70 attached thereon. FIG. 7a shows
enlarged side views of four shaped electrodes with projected
fields used in the apparatus of FIGS. Sa, Sb and 6. FIG. 7b
illustrates the axial views of the four shaped electrodes of
FIG. 7a with respective projected fields.
Referring to FIGS. 6, 7a and 7b, the electrodes 40-70 on the
lead 3 0 can include a non-conducting material, such as but not
limited to insulating material, and the like, on one side or on
a portion of the electrode. Examples, of non-conducting
material can include but are not limited to rubbers, elastomers, plastics, coated metals, and the like, and combinations thereof, and the like.
This nonconductive material can also be used to help direct
electrical field emissions to one side or to more specific
regions, and/or points, rather than to a 360-degree emission.
The invention can include a lead 30 can having a single
electrode with a nonconductive surface region.
Alternatively, more than one electrode can be used on the
lead in series to one another. The nonconductive surface
region can be applied on the same side of the electrodes, or to
different side surface portions of the electrodes as needed.
Additionally, different combinations can be used. For
example, an upper electrode can emit up to 360 degrees while
other electrodes are directed to emit in specific regions and/or
points.

Additionally, circuitry can be added to control which electrodes are being emitted at selected time periods, and the like.
For example, electrodes can be further programmed with a
microprocessor, to activate simultaneously and/or sequentially, and/or staggered and/or over different combinations,
and the like. The invention can use directional type electrodes, such as those shown and described in reference to U.S.
Published Patent Application 2002/0183817 to Van Venrooij
et al., which is incorporated by reference.
The miniaturized implantable electrode apparatus and
stimulation systems can also include those described in U.S.
Patent Application 20030023297, to Byers et al. filed on Jan.
30, 2003, which is incorporated by reference. This reference
describes an eyelid stimulation system and circuitry that
causes a paralyzed eyelid to close or open by passing an
electrical stimulating current to a nerve.
The invention can be used to treat brain impulse bursts and
the resultant physical extremity tremors that result therefrom.
FI GS. Sa and Sb represent untreated brain impulse bursts and
resultant physical extremity tremor outcome that are
untreated. FIG. Sa shows the recording of impulse bursts
from the brain B, that results from the leads 30 that are
connected to the electrodes 40-70 (of the apparatus ofFIG. 6).
The large amplitude bursts represent the impulses that result
in the tremors (impulses from brain to effected extremity).
FIG. Sb represents an extremity that is being affected by the
impulse (here for example, a single index right hand finger).
A laser measuring sensor was aimed at the index finger to
record the results shown in FIG. Sb. For example, a plus 5 mm
apex reading would represent the finger moving forward from
a horizontal plane, and -5 mm represents the finger moving
aft in the horizontal direction.
The invention can use a triggering algorithm to selectively
activate electrodes and treat effected parts of the brain where
impulse bursts occur. FIG. 9 shows an example flow chart of
a triggering algorithm steps that can be used with the invention. The triggering algorithm can take a number of forms or
be adaptive, based on patient neuro-generative responses. In a
simple illustrative form, not intended to be limiting, triggering sensing can be based on exceeding a threshold-firing rate
measured in impulses/second.
FIG. 9 shows an exemplary triggering algorithm 200 for
using the electrodes 40-70 of the preferred embodiment
shown in the preceding figures that switches back and forth
between a sensing mode and transmitting mode. In the first
step 210, signals coming from leads 30 from the microelectrodes 40-70 in the implant receive a signal from the
electrodes 40-70 (the first left trace signal from FIG. Sa) can
be passed through a noise amplitude filter220 (for example an
high pass amplitude filter cutting off a low frequency of for
example everything below approximately 20 mill volts is
filtered out). Next during step 230, the filtered signal goes to
an impulse counter, such as a clock counter which can count
the number of impulses passing through, which can be represented in impulses per second. Next step 240, has an
impulse firing threshold type circuit that can be used that
filters out false alarms and allows for a selected threshold,
such as for example, 5 impulses within 50 milli-seconds,
would trigger the generator in step 2SO to send a generated
pulse SP back down the signal leads 30 to the electrodes

10

15

20

25

30

35

40

45

50

55

60

40-70.

65

When the generator is triggered, a signal can also be sent
(along line Off) to simultaneously shut off the sensing mode
of the electrodes, allowing the electrodes to be in a transmitting mode state. Sensing mode parameters of the electrodes
40-70 can be in approximately 20 to approximately 60 millivolts, while the transmitting/triggering range of the elec-
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trodes 40-70 can be approximately 2 to approximately 4 volts.
The novel triggering algorithm 200 allows the electrodes
40-70 to be switched back and forth between transmitting and
sensing modes without overloading the circuit components,
and thus maximizing power usage during operation.
Once triggered, stimulation blocking continues until firing
impulse firing rate drops below the critical threshold value.
The sensing and stimulation can use the same micro-electrode leads, alternatively, wherein the sensing circuitry first
uses an impulse counter/clock, then if threshold is exceeded,
circuit switching turns "off' the sensor and turns "on" the
stimulator for one or more pulses.
Various triggering algorithms can be developed for effective symptom suppression with animal studies. However, the
safety of this invention's procedure has already been established for humans with continuous and higher pulse rates
through FDA (Food and Drug Administration) approval. Further, a market also exists for electronic retrofit to thousands of
patients who have already been implanted previously, without
further brain surgery since the existing DBS electrodes can
serve as a two-way bi-directional conductor.
In vitro testing of this approach also can be possible using
current systems by sensing electro-magnetic forces from subcutaneous wires of a neurological event onset, such as the
beginning of a tremor. These signals, then in tum, can allow
the triggering of the existing magnetic switch for turn "off'
and "on."
Other types of triggering mechanisms can include those
described in U.S. Pat. No. 6,539,263 to Schiff; U.S. Pat. No.
6,366,813 to DiLorenzo; U.S. Pat. No. 6,301,492 to Zonenshayn; U.S. Pat. No. 6,038,480 to-Hrdlicka et al.; U.S. Pat.
No. 5,833,709 to Rise et al.; U.S. Pat. No. 5,716,377 to Rise
et al.; and U.S. Pat. No. 5,707,396 to Benabid, which are all
incorporated by reference. Additionally, U.S. Patent Applications 20030181954 to Rezai; 20030085684 to Tsukamoto et
al.; and 20020188330 to Frans et al., which are all incorporated by reference,
FIGS. 10, lOa and lOb shows a layout of the electronic
components that can be used in the apparatus of FIGS. Sa, Sb,
6 along with the triggering algorithm of FIG. 9. Referring to
FIGS. Sa, Sb, 6, 10, lOa and lOb, the cap 20 can include
miniaturized components that include a battery type power
supply 110, which provides power to a stimulation generator
controller 120, which is triggered by a triggering switch 2SO
which receives signals from a sensing circuit 140 all of which
are connected to electrodes 40-70 on lead line 30 that is
implanted into the skull 310 of the patient 300.
The invention can make use of ultra-miniature batteries
110 such as those, manufactured by Advanced Bionics Corp.,
which are only about 1!3s the size of a standard AA battery and
now serve medical implants by emitting electrical micropulses that stimulate nearby nerves. These tiny batteries, or
"Bions," can also be can be programmed from outside the
body for strength and frequency of the stimulation, and wirelessly recharged with an electrical field. The use of these
ultra-miniature batteries would avoid both a chief source of
complaints; the remotely implanted card-deck sized stimulator/battery [about 60 by about 80 by about 15 mm] in the chest
area, its replacement, while also avoiding problems associated with vulnerable wire leads under the skin from the chest
area to connect with the implant on the skull.
The Stimulation Generator Controller 120 can be a solidstate device such as the one shown and described in the
Medtronic's Model 3628 cited 0093 of U.S. Published Patent
Application No. 2002/0183817 to Van Venrooij et al., which
is incorporated by reference. Trigger Switch 130 can be a
common mini-double throw "on-off' and "off-on" electronic

switch, triggering based on sensing circuit threshold. The
Sensing Circuit 140 can be a common solid-state impulse
counter-clock, e.g. mini-version of cardiac-alarm, monitoring electrical impulses to heart
The circuits are powered by miniature battery 110 as
shown in FIG. lOb. The sensing circuit 140 can include the
noise amplitude filter 220 and impulse counter 230 of FIG. 9.
The trigger switch 130 is activated when threshold circuit 240
of FIG. 9 is exceeded to tum "off' the sensor input and tum
"on" the stimulation generator 120. This is reversed when the
impulse is blocked, dropping below threshold.
The components to run the novel invention can be fit into a
space of approximately 60 mil by 15 mil compared to prior
art. Conservatively less than 50% of the current 60 by about
80 by about 15 mm in a plastic skull-cap implant see FIG. 6.
The invention can be less expensive than the current techniques, since no surgery tunneling down the neck into the
chest area is needed for the battery cards, and thus no repairs
or surgery for those components-which currently about $10,
000 every 3-5 years.
Benefits of using the novel triggering algorithm of FIG. 9
and apparatus components of FIGS. Sa, Sb, 6, 10 and FIGS.
lla- llc, 12a-12c.
FIG. lla shows a trace graph of the neuronal impulse
bursts in mill volts verses time of a patient being treated with
a Medtronic type (prior art) technique such as the one shown
and described in reference to U.S. Patent Application Publication 2002/0183817 to Van Venrooij et al., which is incorporated by reference. FIG. llb shows a trace graph of the
associated tremor displacement for FIG. llb verses time of
the patient being treated with the Medtronic type (prior art)
technique. FIG. llc shows the continuing pulse train that
occurs with the Medtronic type (prior art) technique which
causes the trace graphs of FIGS. lla-llb.
Referring to FIGS. lla-llc, results in a continuing pulse
train (FIG. llc) in order to cause the effects of no impulse
bursts (FIG. lla) and no resultant physical tremors (FIG.
llb ).As described in the background section of this invention
this technique requires continuously generating pulsed type
signals once the electrodes are activated whether or not a
brain type tremor has ended, which would result in needless
and excessive, unwanted and potentially dangerous electrical
current being continuously generated inside the brain. The
more unnecessary pulse type signals, the more undesirable
side effects to the patient.
Additionally, the technique proposed in this patent application publication would require excessive power to operate,
which are not only expensive since battery power supplies
would need to be constantly replaced but also require large
card size batteries that must be externally mounted outside of
a patient or mounted inside of the upper chest or be constantly
connected to an external power supply. This proposed
Medtronic technique would also be prone to short circuit
since the electrodes would be simultaneously operating as
both transmitters and sensors, which also causes excessive
and unnecessary power drain, which also shortens the
lifespan of any batteries being used as well as increase the
costs for replacing the batteries.
FIG. 12a shows a trace graph of the neuronal impulse
bursts in mill volts verses time of a patient being treated from
being treated by the subject invention described above. FIG.
l2b shows a trace graph of the associated tremor displacement for FIG. 12a verses time of the patient being treated by
the subject invention. FIG. 12c shows the single pulses that
occur with the subject invention technique which results in
the trace graphs of FIGS. 12a-12b.
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Referring to FIGS. 12a-12c, the invention causes single
spaced apart pulses to occur over greater periods of time,
where each pulse occurs on-demand, and not as a continuous
series of pulses. As shown by FIG. 12a, the initial impulse
burst and subsequent impulse bursts have long delay time
periods there between, which can result in substantially
reduced or eliminated tremors resulting therefrom, FIG. llb.
The novel invention allows for less undesirable electrical
current to be generated within the brain, less side effects that
result therefrom, less power consumption as well as other
apparent benefits. The novel invention can use small batteries
that were not able to be used in the prior art systems and
techniques, and also results in power supplies that require less
replacements as well. The novel invention is able to eliminate
the need for large and cumbersome card type batteries or
external power supplies, and results in a better system for
treatment.
Differences between the subject invention and that
described in the Medtronic technique shown in U.S. Patent
Application Publication 2002/0183817 to Van Venrooij et al.
are compiled in Table 1.
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TABLE 1
Comparison of prior art(Medtronic) and Invention.

Attribute
Sensing
Trigger
Objective
Stimulator
Power

Medtronic

Loss of Effectiveness
Brain "Activity"
Select Electrodes
Normally-On
No "off'
(continuing pulses)
Large Battery
Limited
Power Lifespan
Battery Mounting "Implantable"
Side Effects
Continuous electrical current

25

Invention

Single Event
Initial Impulse Burst
Stop Single Tremor
Normally-Off
Only "on"as needed
(individual pulse)
Small Battery
Extended
Skull-Mounted in Cap
Limited Electrical Current

Besides circuitry miniaturization, by triggering pulse generation only when needed, fewer pulses per second also can
reduce some of the mild, but known side effects of DBS, and
the timed delivery also can delay the onset of the next event by
physiological feedback, that is also known to be effective
against a known clinical phenomena Parkinson's Disease.
Other advantages can also be realized. The timed pulse
feedback speculatively could induce the brain to adaptively
alter actual neural circuitry, allowing a further reduction of
pulse rate and even more efficiency or even better help reduce
symptoms naturally, just as brain circuitry is known to be
altered by experience.
While the invention has been described for use with tremors, the invention can have applicability to other medical
applications, such as but not limited to movement disorders
and cardiac dysfunctions, but extends to include other neurological diseases and disorders such as epilepsy, psychiatric
and behavioral dysfunctions such as schizophrenia and druginduced symptoms and the like.
While the invention has been described, disclosed, illustrated and shown in various terms of certain embodiments or
modifications which it has presumed in practice, the scope of
the invention is not intended to be, nor should it be deemed to
be, limited thereby and such other modifications or embodiments as may be suggested by the teachings herein are particularly reserved especially as they fall within the breadth
and scope of the claims here appended.
We claim:
1. A method for providing deep brain stimulation (DBS),
consisting of the steps of:
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providing an implantable pulse stimulator with battery
supply and miniaturized controller within one single
self-contained elongated pro be for sensing and stimulating to eliminate spatially separated detection and stimulation electrodes, the providing step includes:
fabricating a single implantable lead line for implanting
in the head of a patient below their skull;
attaching four electrodes to an exterior surface of the
single implantable lead line for sensing and transmitting for both sensing and stimulating, wherein one of
the four electrodes emits in an approximately 360
degree field about the implantable lead line, and the
other electrodes emit in selected directional regions;
forming a single cylindrical disc housing, the single
cylindrical disc housing containing components that
fit into a space of approximately 60 millimeters in
diameter by approximately 15 millimeters in height;
extending the single implantable lead line beneath a
center portion of the single cylindrical disc housing;
enclosing the battery supply and the miniaturized controller as the components inside a compartment of the
single cylindrical disc housing without implanting
any batteries in a chest area of a user and avoiding use
of any wires under skin from the chest area to connect
to the stimulator, the compartment in the cylindrical
disc housing contains a hole with the components
arranged around the hole;
internally connecting the electrodes through the single
implantable lead line to the controller located inside
of the cylindrical disc housing; and
forming a top disc cover having perimeter side edges;
covering the compartment in the cylindrical disc housing with the top disc cover having the perimeter side
edges;
producing a fully enclosed single self-contained deep
brain simulation probe with both the cylindrical disc
housing, the top disc cover and the single lead line so
as to avoid the risk of implanting more than one single
probe into different spatially separated areas of the
brain;
imbedding only the single implantable lead line which
extends beneath the one single self-contained probe
below a single opening in the sknll of the user into one
single area of a brain as a self-contained bi-directional
conduit for deep brain stimulation;
capping the skull with the single cylindrical disc housing
and the top disc cover so that the single cylindrical disc
housing with the top disc cover is positioned as a cap on
top of the skull above the single opening in the skull;
covering the cylindrical disc housing and the top disc cover
with the scalp so that the height of the cylindrical disc
housing and the top disc cover protrudes so as to not
cause a noticeable protrusion on the head of the user;
sensing an initiation of an unwanted electro-physiologically signaled event of an impulse burst in an area of the
brain of the user caused by a condition using one of the
electrodes, wherein the sensing of the initiation includes
the steps of:
filtering sensed signals of the impulse burst from the one
electrode to a noise amplitude filter;
counting impulses in the filtered signals with an impulse
counter; and
triggering the single treatment pulse when a selected
threshold of the counted impulse has been reached;
and
selectively generating a single treatment pulse only from
the one electrode to only the area of the brain of the
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user, the single pulse being selectively generated on
demand of the sensed initiation of unwanted electrophysiologically signaled event of the impulse burst
caused by the condition without user intervention, the
sensing and stimulating of the electrodes being alternatively active.
2. The method of claim 1, wherein the step of generating
includes generating a non-continuous spaced apart pulse
upon occurrence of a follow-up sensed impulse burst.
3. The method of claim 1, wherein the condition includes:
a tremor.
4. The method of claim 1, wherein the providing step
includes:
providing a processor based controller for executing
a set of monitoring instructions for sensing initiation of an
unwanted electro-physiologically signaled event, and
a set of triggering instructions for activating the stimulator
to generate the single treatment pulse, the monitoring
and sensing being alternately activated.
5. Thu method of claim 1, wherein the sensing step
includes
sensing modes in the electrodes between approximately 20
to approximately 60 milli-volts, and
triggering the electrodes between approximately 2 to
approximately 4 volts, wherein
the electrodes switch back and forth between sensing and
triggering modes without overloading circuit components, and thus maximizing power usage during operation.
6. The method of claim 1, wherein the filtering step
includes
filtering out false alarms and allowing for a selected threshold value with an impulse firing threshold circuit.
7. The method of claim 6, wherein the threshold value
includes approximately 5 impulses within approximately 50
milli-seconds.
8. The method of claim 1, wherein the enclosing the battery
step includes
wirelessly recharging the battery supply by an external
electric field.
9. The method of claim 1, wherein the sensed impulse burst
includes a tremor of approximately 5 to approximately 7
tremor cycles per second.
10. The method of claim 1, wherein the sensed impulse
burst includes a tremor of approximately 3 to approximately
5 tremor cycles per second.
11. A method for providing deep brain stimulation (DBS),
consisting of the steps of:
providing a single lead line having a plurality of electrodes,
wherein each of the electrodes alternate from being a
detection electrode and a stimulation electrode, the
single lead line having a diameter;
providing a single cylindrical disc housing, having components that fit within a space of approximately 60 millimeters in diameter by approximately 15 millimeters in
height;
housing a battery supply and a controller for controlling the
detection electrode and stimulation electrode inside a
compartment in the single cylindrical disc housing, the
compartment in the cylindrical housing contains a hole
with the components arranged around the hole; within
one single self-contained elongated probe for sensing
and stimulating to eliminate spatially separated detection and stimulation electrodes, the providing step
includes:
fabricating a single implantable lead line for implanting
in the head of a patient below their skull;

covering the cylindrical disc housing with the top disc
cover having perimeter side edges that cover the compartment in the cylindrical disc housing;
attaching the single lead line through a center of a bottom of the cylindrical disc housing;
imbedding only the single lead line below a single opening in the skull;
capping the skull with the single cylindrical disc housing
and the top disc cover so that the single cylindrical
disc housing with the top disc cover is positioned as a
cap mounted on top of the skull above the single
opening in the skull;
covering the cylindrical disc housing and the top disc cover
with the scalp so that the height of the cylindrical disc
housing and the top disc cover protrudes so as to not
cause a noticeable protrusion on the head of the user;
sensing an initiation of an unwanted electro-physiologically signaled event of an impulse burst in the user
caused by a condition in an area of the brain using one of
the plurality of the electrodes on the lead line; and
selectively generating a single treatment pulse from the
one electrode to the area of the brain of the user on
demand of the sensed initiation of unwanted electrophysiologically signaled event of the impulse burst
caused by the condition.
12. The method of claim 11, wherein the sensing step
includes
filtering sensed signals from electrode sensors to a noise
amplitude filter,
counting impulses in the filtered signals with an impulse
counter, and
triggering the single treatment pulse when a selected
threshold of the counted impulses has been reached.
13. The method of claim 12, wherein the sensing step
includes
sensing modes in the electrodes between approximately 20
to approximately 60 milli-volts, and
triggering the electrodes between approximately 2 to
approximately 4 volts, wherein
the electrodes switch back and forth between sensing and
triggering modes without overloading circuit components, and thus maximizing power usage during operation.
14. The method of claim 11, wherein the filtering step
includes
filtering out false alarms and allowing for a selected threshold value with an impulse firing threshold circuit.
15. The method of claim 14, wherein the threshold value
includes approximately 5 impulses within approximately 50
milli-seconds.
16. The method of claim 14, wherein the housing the battery supply step includes
wirelessly recharging the battery supply wireless by an
external electric field.
17. The method of claim 11, wherein the sensed impulse
burst includes a tremor of approximately 5 to approximately
7 tremor cycles per second.
18. The method of claim 11, wherein the sensed impulse
burst includes a tremor of approximately 3 to approximately
5 tremor cycles per second.
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